NDC 63323-327-21 - Nafcillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-327
- Requested NDC
- 63323-327-21
- Package NDCs from labels
- 63323-327-21, 63323-327-10
- Manufacturer
- Fresenius Kabi USA, LLC | Istituto Biochimico Italiano G. Lorenzini S.p.A.
- Effective date
- 2019-05-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nafcillin for Injection, USP | Fresenius Kabi USA, LLC | Istituto Biochimico Italiano G. Lorenzini S.p.A. | 2019-05-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-327-10 | Nafcillin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-327-21 | Nafcillin | 4 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 4 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-327-10 | EA - Each | 63323-327 | 4458849f-3ef3-411a-8d7d-6fa9f2286d10 | 1 | 2012-07-24 |
| 63323-327-21 | EA - Each | 63323-327 | 81dc295b-e34a-490d-a39b-47df646ecc02 | 1 | 2025-11-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| NAFCILLIN | ACTIVE MOIETY | 4CNZ27M7RV | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nafcillin | NAFCILLIN SODIUM | Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | 8a00624c-c436-4102-a042-dab54022bcc2 | 2026-07-28 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Nafcillin | NAFCILLIN | WG Critical Care, LLC | 77999cd2-17b8-4df9-b687-d0f9b62096b9 | 2026-06-24 | Warnings, Adverse reactions | 49G3001BCK |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 1Q73Q2JULR |
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 4b3b8e52-df96-4886-e063-6294a90ac63f | 2026-03-09 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC128D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 251fd4cb-4aa4-4473-9f89-968da856eb77 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC127D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 75a008b2-9666-4bfa-ab18-6d09b43b2215 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 1Q73Q2JULR |
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | 1Q73Q2JULR |
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 1Q73Q2JULR |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | 1Q73Q2JULR | |
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | Armas Pharmaceuticals Inc. | 090fda61-b9c8-640e-e063-6294a90a7363 | 2025-09-30 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Eugia US LLC | 90717878-64cb-4ffc-90bc-7b4e81e3d1cd | 2025-08-16 | Warnings, Adverse reactions | 1721458 1721460 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Eugia US LLC | 8ec288e6-4d7f-4fea-a5ab-f9f337ebaa86 | 2025-08-16 | Warnings, Adverse reactions | 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Eugia US LLC | 34821770-929c-40ea-a9e4-d4405dc869e1 | 2025-08-12 | Warnings, Adverse reactions | 1721460 49G3001BCK |
| Nafcillin | NAFCILLIN SODIUM | Eugia US LLC | 0f21384c-0f82-4d99-a05c-6773d1ee4bcf | 2025-08-12 | Warnings, Adverse reactions | 49G3001BCK |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | 1Q73Q2JULR |
| Insecticides/Pest/Food Additives Detox | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Dr. Donna Restivo DC | b5778211-0e3e-44ef-bd65-a76a68cf1504 | 2025-05-23 | Warnings | 1Q73Q2JULR |